Citrate in the management of urolithiasis

Journal of Endourology

Volumn 13, Issue 9, 1999, Pages 687-692

  Pattaras, John G ^a   Moore, Robert G ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE CALCIUM; CITRATE POTASSIUM; CITRATE SODIUM; CITRIC ACID; MAGNESIUM CITRATE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ARTICLE; CITRIC ACID CYCLE; HUMAN; PRIORITY JOURNAL; STONE FORMATION; SUPPLEMENTATION; URINE LEVEL; UROLITHIASIS;

EID: 0032762799     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.1999.13.687     Document Type: Article

References (37)

1. Prevention and Treatment of Kidney Stones. NIH Consensus Statement Online 1988;7(1):1.
2. Fleisch H. Inhibitors and promoters of stone formation. Kidney Int 1978;23:361.
3. Welshman SG, McGeown MG. Urinary citrates incalcium urolithiasis. Proc Soc Exp Biol Med 1976;46:216.
4. Kok DJ, Papapoulos SE, Bijvoet OL. Excessive crystal agglomeration with low citrate excretion in recurrent stone formers. lancet 1986;1:1056.
5. Menon M, Mahle CJ. Urinary citrate excretion in patients with renal calculi. J Urol 1983;129:1158.
6. Rudman D, Kutner MH, Redd SC II, et al. Hypocitrauria in calcium nephrolithiasis. J Clin Endocrin Metab 1982;55:1052.
7. Nicar MJ, Skurla C, Sakhaee K, et al. Low urinary citrate excretion in nephrolithiasis. Urology 1983;1:8.
8. Boothby WM, Adams M. The occurrence of citric acid in urine and body fluids. Am J Physiol 1934;107:471.
9. Laminski NA, Meyers AM, Sonnekus MI, Smyth AE. Prevalence of hypocitrauria and hypopyrophosphaturia in recurrent calcium stone formers: As isolated defects or associated with other metabolic abnormalities. Nephron 1990;56:379.
10. Pak CYC: Hypercalciuric calcium nephrolithiasis. In: Resnick MI, Pak CYC (eds): Urolithiasis: A Medical and Surgical Reference. Philadelphia: WB Saunders, 1990, pp 79-88.
11. Meyer JL, Smith LH. Growth and calcium oxalate crystals II: Inhibition by natural urinary crystal growth inhibitors. Invest Urol 1975;13:36.
12. Tiselius HG, Fornander AM, Nilsson MA. The effects of citrate and urine on calcium oxalate crystal aggregation. Urol Res 1993;21:363.
13. Hess B, Zipperle L, Jaeger P. Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 1993;265:F784.
14. Nieth H, Schollmeyer P. Citratstoffwechsel der menschlichen Niere. Verh Dtsch Ges Inn Med 1965;71:693.
15. Norman ME, Feldman HI, Cohn RM, et al. Urinary citrate excretion in the diagnosis of distal renal tubular acidosis. J Pediatr 1978;92:394.
16. Nicar MJ, Peterson R, Pak CYC. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol 1984;131:430.
17. Pak CYC, Peterson R, Sakhaee K, et al. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med 1985;79:284.
18. Kok DJ, Iestra JA, Doorenbos CJ, Papapoulos SE. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab 1990;71:861.
19. Wasserstein AG. Nephrology for the generalist I. DM 1998;44:203.
20. Fegan J, Khan P, Pointdexter J, Pak CYC. Gastrointestinal citrate absorption in nephrolithiasis. J Urol 1992;147:1212.
21. Minisola S, Rossi W, Pacitti MI, et al. Studies on citrate metabolism in normal subjects and kidney stone patients. Min Electrol Metab 1989;15:303.
22. Sakhaee K, Nicar M, Hill K, Pak CYC. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 1983;24:348.
23. Pak CYC, Peterson R. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med 1986;146:863.
24. Harvey JA, Kenny P, Pointdexter J, et al. Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting. J Am Ceram Soc 1990;9:583.
25. Levine BS, Rodman JS, Wienerman S, et al. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: Implications for prevention of osteoporosis. Am J Clin Nutr 1994;60:592.
26. Sakhaee K, Baker S, Zerwekh J, et al. Limited risk of kidney stone formation during long-term calcium citrate supplementation in non-stone forming subjects. J Urol 1994;152:324.
27. Ettinger B, Pak CYC, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997;158:2069.
28. Meyer JL, Smith LH. Growth of calcium oxalate crystals I: A model for urinary stone growth. Invest Urol 1975;13:31.
29. Schmiedl A, Schwille PO, Berge B, et al. Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat: Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate. Urol Int 1998;61:76.
30. Koenig K, Padalino P, Alexandrides, Pak CYC. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. J Urol 1991;145:330.
31. Trinchieri A, Ostini F, Nespoli R, Rovera F, et al. A prospective study of recurrence rate and risk fcators for recurrence after a first renal stone. J Urol 1999;162:27.
32. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol 1984;56:122.
33. Beck EM, Riehle RA. The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. J Urol 1991;145:6.
34. Trinchieri A, Mandressi A, Zanetti G, et al. Recurrence of lithiasis after extracorporeal lithotripsy, percutaneous surgery, and open surgery for calculi of the upper urinary tract. Prog Urol 1992;2:396.
35. Fine J, Pak CYC, Preminger GM. Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 1995;153:27.
36. Cicerello E, Merlo F, Gambaro G, et al. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection patients. J Urol 1994;151:5.
37. Preminger GM. New developments in the management of urolithiasis. In Lingeman J, Preminger GM (eds): Topics in Clinical Urology. New York: Igaku-Shoin Medical Publishers. 1998, pp 183-193.